NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Prescribing
  • Key to symbols

15 Anaesthesia

15.2 Local anaesthesia

Total Formulary
LEVOBUPIVACAINE

Restrictions: Restricted to specialist initiation.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/86456.htm

LIDOCAINE AND PHENYLEPHRINE

Restrictions: Restricted to specialist initiation.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/74859.htm#_74859

LIDOCAINE AND PRILOCAINE (EMLA) (cream)

Restrictions:

Restricted to specialist initiation.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/6693.htm#_6693

PHENOL

Restrictions: Restricted to specialist initiation.

PRILOCAINE

Restrictions: Restricted to specialist initiation.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/6702.htm

PROCAINE

Restrictions: Restricted to specialist initiation.

LIDOCAINE (LMX4) (CREAM)

Restrictions: Restricted to use in hospitals only.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/202238.htm#_202238

PRILOCAINE HYDROCHLORIDE (PRILOTEKAL) (SOLUTION)

Restrictions: Restricted to use in spinal anaesthesia in ambulatory surgery settings such as day surgery units.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/6702.htm

BUPIVACAINE

Restrictions: Restricted to specialist initiation.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/6697.htm

BUPIVICAINE AND FENTANYL (BUFYL) (epidural)

Restrictions: Restricted to specialist use for epidural analgesia to relieve pain during labour and to control post operative pain.

COCAINE

Restrictions: Restricted to specialist initiation.

Prescribing Notes:

Exludes spray formulations.

LIDOCAINE
LIDOCAINE (MEDICATED PLASTER)

Restrictions:

Restricted to patients who are intolerant of first line therapies for post-herpetic neuralgia or where these therapies have been ineffective. Use for other indications remain non-Formulary.

Prescribing Notes:

In the acute sector, the use of lidocaine plasters for any indication (licensed or otherwise) must be supported by completion of the Lidocaine Plaster Alert Monitoring Form (except where being used in palliative care).

A blog containing recommendations on the use of lidocaine plasters in the acute sector will be published in May 2019.

If lidocaine plasters are initiated for analgesia (in accordance with formulary restrictions), the patient should be reviewed at 4 weeks and treatment only continued if the patient demonstrates a response.  If no response, treatment should be discontinued.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/130131.htm#_130131

TETRACAINE (GEL)

Restrictions: Restricted to specialist initiation.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/40703.htm